Hiraiwa H, Okumura T, Kondo T, Kato T, Kazama S, Ishihara T, Iwata E, Shimojo M, Kondo S, Aoki S, Kanzaki Y, Tanimura D, Sano H, Awaji Y, Yamada S, Murohara T (2020)
Usefulness of the plasma branched-chain amino acid/aromatic amino acid ratio for predicting future cardiac events in patients with heart failure
J Cardiol

Sato T, Tatekoshi A, Takada K, Iyama S, Kamihara Y, Jawaid P, Rehman MU, Noguchi K, Kondo T, Kajikawa S, Arita K, Wada A, Murakami J, Arai M, Yasuda I, Dang NH, Hatano R, Iwao N, Ohnuma K, Morimoto C (2019)
DPP8 is a novel therapeutic target for multiple myeloma
Sci Rep 9: 18094

Ito M, Kusuhara H, Ose A, Kondo T, Tanabe K, Nakayama H, Horita S, Fujita T, Sugiyama Y (2017)
Pharmacokinetic Modeling and Monte Carlo Simulation to Predict Interindividual Variability in Human Exposure to Oseltamivir and Its Active Metabolite, Ro 64-0802
AAPS J 19: 286

Kakehi M, Tagawa Y, Goto A, Kondo T, Asahi S (2016)
The effects of the concentration-dependent erythrocyte distribution of TAK-802, a potent acetylcholinesterase inhibitor, on rat pharmacokinetics
Biopharmaceutics & Drug Disposition 37: 467

Nishihara M, Takahashi J, Kondo T, Mouri K, Asahi S (2014)
Main metabolic pathways of TAK-802, a novel drug candidate for voiding dysfunction, in humans: the involvement of carbonyl reduction by 11beta-hydroxysteroid dehydrogenase 1
Drug Res (Stuttg) 64: 476

Hosoya N, Sakumoto M, Nakamura Y, Narisawa T, Bilim V, Motoyama T, Tomita Y, Kondo T (2013)
Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma
Biochimica & Biophysica Acta 1834: 2630

Kakehi M, Tagawa Y, Kondo T, Asahi S (2013)
Disposition of the new potent acetylcholinesterase inhibitor 8-[3-[1-[(3-fluorophenyl)methyl]-4-piperidiny]-1-oxopropyl]-1, 2, 5, 6-tetrahydro-4H-pyrrolo [3, 2, 1-ij] quinolin-4-one (TAK-802) in rats, dogs and monkeys
Drug Res (Stuttg) 63: 293

Ueyama J, Satoh T, Kondo T, Takagi K, Shibata E, Goto M, Kimata A, Saito I, Hasegawa T, Wakusawa S, Kamijima M (2010)
Beta-glucuronidase activity is a sensitive biomarker to assess low-level organophosphorus insecticide exposure
Toxicol Lett 193: 115

Nakahata K, Kinoshita H, Hama-Tomioka K, Ishida Y, Matsuda N, Hatakeyama N, Haba M, Kondo T, Hatano Y (2008)
Cholinesterase inhibitor donepezil dilates cerebral parenchymal arterioles via the activation of neuronal nitric oxide synthase
Anesthesiology 109: 124

Ueyama J, Kamijima M, Asai K, Mochizuki A, Wang D, Kondo T, Suzuki T, Takagi K, Kanazawa H, Miyamoto K, Wakusawa S, Hasegawa T (2008)
Effect of the organophosphorus pesticide diazinon on glucose tolerance in type 2 diabetic rats
Toxicol Lett 182: 42

Kondo T, Nekado T, Sugimoto I, Ochi K, Takai S, Kinoshita A, Tajima Y, Yamamoto S, Kawabata K, Nakai H, Toda M (2007)
Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration
Bioorganic & Medicinal Chemistry 15: 2631

Ueyama J, Wang D, Kondo T, Saito I, Takagi K, Kamijima M, Nakajima T, Miyamoto K, Wakusawa S, Hasegawa T (2007)
Toxicity of diazinon and its metabolites increases in diabetic rats
Toxicol Lett 170: 229

Okamura A, Kamijima M, Shibata E, Ohtani K, Takagi K, Ueyama J, Watanabe Y, Omura M, Wang H, Ichihara G, Kondo T, Nakajima T (2005)
A comprehensive evaluation of the testicular toxicity of dichlorvos in Wistar rats
Toxicology 213: 129

Mima J, Kondo T, Hayashi R (2002)
N-terminal acetyl group is essential for the inhibitory function of carboxypeptidase Y inhibitor (I(C))
FEBS Letters 532: 207

Tarutani O, Kondo T, Shulman S (1977)
Properties of carbohydrate-stripped thyroglobulin. III. Solubility characteristics of thyroglobulin
Biochimica & Biophysica Acta 492: 284